How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.
about
Preexposure prophylaxis-related stigma: strategies to improve uptake and adherence - a narrative reviewPre-exposure prophylaxis for sexually-acquired HIV risk management: a reviewCombination HIV prevention interventions: the potential of integrated behavioral and biomedical approachesOral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challengesPharmaceutical HIV prevention technologies in the UK: six domains for social science researchApplying a PrEP Continuum of Care for Men Who Have Sex With Men in Atlanta, GeorgiaTowards preparedness for PrEP: PrEP awareness and acceptability among MSM at high risk of HIV transmission who use sociosexual media in four Celtic nations: Scotland, Wales, Northern Ireland and The Republic of Ireland: an online survey."In reality, it is complex and difficult": UK nurses' perspectives on "treatment as prevention" within HIV care.High interest in preexposure prophylaxis among men who have sex with men at risk for HIV infection: baseline data from the US PrEP demonstration project.Awareness of pre-exposure prophylaxis (PrEP) among women who inject drugs in NYC: the importance of networks and syringe exchange programs for HIV prevention.Adherence to preexposure prophylaxis: current, emerging, and anticipated bases of evidence.Access to healthcare, HIV/STI testing, and preferred pre-exposure prophylaxis providers among men who have sex with men and men who engage in street-based sex work in the US.Australian gay and bisexual men's attitudes to HIV treatment as prevention in repeated, national surveys, 2011-2013.Barriers to uptake and use of pre-exposure prophylaxis (PrEP) among communities most affected by HIV in the UK: findings from a qualitative study in ScotlandAttitudes and perceptions of biomedical HIV prevention methods: voices from young men who have sex with menKnowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV.Sexual behaviours of men who inject drugs in northeast IndiaIntimacy, condom use, and pre-exposure prophylaxis (PReP) acceptability among men who have sex with men (MSM) in primary partnerships: a comment on Gamarel and Golub.Sexual behaviours of homosexual and bisexual men in France: a generational approach.Substance-use and sexual harm reduction strategies of methamphetamine-using men who have sex with men and inject drugs.Key factors in the acceptability of treatment as prevention (TasP) in Scotland: a qualitative study with communities affected by HIV.Feasible, Efficient and Necessary, without Exception - Working with Sex Workers Interrupts HIV/STI Transmission and Brings Treatment to Many in Need.Willingness to Act upon Beliefs about 'Treatment as Prevention' among Australian Gay and Bisexual Men.Complex and Conflicting Social Norms: Implications for Implementation of Future HIV Pre-Exposure Prophylaxis (PrEP) Interventions in Vancouver, Canada.Implementation challenges and opportunities for HIV Treatment as Prevention (TasP) among young men in Vancouver, Canada: a qualitative studyWho Will Use Pre-Exposure Prophylaxis (PrEP) and Why?: Understanding PrEP Awareness and Acceptability amongst Men Who Have Sex with Men in the UK--A Mixed Methods Study.Female Condom Use and Adoption Among Men and Women in a General Low-Income Urban U.S. Population.PrEP Awareness and Attitudes in a National Survey of Primary Care Clinicians in the United States, 2009-2015.PEP and TasP Awareness among Italian MSM, PLWHA, and High-Risk Heterosexuals and Demographic, Behavioral, and Social CorrelatesMinimal Awareness and Stalled Uptake of Pre-Exposure Prophylaxis (PrEP) Among at Risk, HIV-Negative, Black Men Who Have Sex with MenPlanning ahead for implementation of long-acting HIV prevention: challenges and opportunities.Explaining the Efficacy of Pre-exposure Prophylaxis (PrEP) for HIV Prevention: A Qualitative Study of Message Framing and Messaging Preferences Among US Men Who have Sex with Men.Influence of Partner Type on Acceptability and Likelihood of Use of a Rectal Microbicide Among Young Men Who Have Sex With Men in the United States and Puerto Rico.Knowledge, Attitudes, and Acceptability of Pre-Exposure Prophylaxis among Individuals Living with HIV in an Urban HIV ClinicWomen want Pre-Exposure Prophylaxis but are Advised Against it by Their HIV-positive CounterpartsEarly Adopters: Correlates of HIV Chemoprophylaxis Use in Recent Online Samples of US Men Who Have Sex with Men.Preexposure Prophylaxis Modality Preferences Among Men Who Have Sex With Men and Use Social Media in the United StatesUse of an HIV-risk screening tool to identify optimal candidates for PrEP scale-up among men who have sex with men in Toronto, Canada: disconnect between objective and subjective HIV risk.Changes in Familiarity with and Willingness to Take Preexposure Prophylaxis in a Longitudinal Study of Highly Sexually Active Gay and Bisexual Men.Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014.
P2860
Q26778293-8D5FD03C-B219-4029-B270-DED42167CE52Q26849762-5A6CCA8E-B4C2-41EB-A2B5-3B40A7B622FEQ27005602-16C3B1E1-9E08-4FAF-9FAA-CB0217D0BB16Q27023352-DC9C1509-35F7-48DE-BCA6-A2C97CD0B738Q28081560-8C3A9EC7-50F4-4830-9CDB-7CC47A4A5DAEQ28088473-ECD3D76A-DDEB-468C-BFF1-B24AA9AA4247Q30196896-530E1673-21F1-4F0B-9E59-39567E4A643FQ30371429-263901AD-1C02-4BB8-86AB-3E804303362EQ30877918-EE6AEAC5-017B-4993-86BA-F51BF94FDF01Q32174089-8591DD46-A753-4A2B-B2DC-E668FFA17FEDQ33765789-7CA635FD-A17D-4BD0-8139-B7913B2945E9Q34489373-CFA31007-B464-4FA1-87A9-24554AB2C625Q34489404-6C42F308-6F8A-4382-8F8D-521EDAD54560Q34573517-C21FB68A-2A42-474E-9564-D87F4C0B3890Q34667743-64877D29-9342-4A36-8FE7-DD69CE6516DEQ35064674-77555800-828B-4F19-BAAF-0B57EF7C0242Q35156331-B5EC4238-E688-4D1D-8830-809EB969110AQ35163705-2917F10A-BFD4-449E-8D5C-88C04E91198AQ35224745-54E0CA59-CA95-4290-8710-071B3854B41FQ35587333-F0B7D044-820F-4893-9DFE-E34C075ADF2FQ35677414-628C39BD-8C94-4831-94B8-967CEED14450Q35816178-21080A34-FE0D-46C6-952A-B8957FF4ECC5Q35887935-E9E3371F-1D00-4C24-93C6-E6966ADBB2A8Q35891499-C9D72CC9-6312-42AD-A192-5506D53B9AA9Q35956696-E8BAF25A-D1A4-4FA2-91F5-C54B5B7D6D25Q35993762-EDB0CEE9-F2FD-4394-B7EA-EBBF4C3E3C67Q36005784-691F0144-06B8-4551-93B6-C7E562A8E361Q36040025-E3AFED40-9FA4-4F30-9303-3E84EF88232EQ36050331-7BEA3CF3-00F7-4297-B9C4-453C3EFAE667Q36148056-EA26F95E-E0DC-46B1-8FC2-1E64D9AAE541Q36204808-634D57BA-F414-455B-BED8-78CB5114DF49Q36276035-BDD863F9-3B4B-43F0-A5A6-FC28AF6615C5Q36421478-C0D6FDFC-920B-4C80-96F5-36C486EA44D8Q36567659-6FB2EA9C-C5A0-4624-B3D6-FE4CFE188A3EQ36728424-D6E1D2B3-7F7A-40C2-92D0-CD3DAF3F2A1BQ36998543-3CD1613F-7AAB-4D6D-8758-54367E438DAEQ37008559-4A680AC5-BE75-42A6-8CE4-C0E12D6E752BQ37015274-13DB856A-DA3E-4273-A675-3844B2FDAA40Q37157147-2209F662-5C3A-4882-9092-EDEB4DF88B64Q37229172-652A81AD-7F96-4E99-8595-8EB55CD115B3
P2860
How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
How acceptable are antiretrovi ...... s and treatment as prevention.
@en
How acceptable are antiretrovi ...... s and treatment as prevention.
@nl
type
label
How acceptable are antiretrovi ...... s and treatment as prevention.
@en
How acceptable are antiretrovi ...... s and treatment as prevention.
@nl
prefLabel
How acceptable are antiretrovi ...... s and treatment as prevention.
@en
How acceptable are antiretrovi ...... s and treatment as prevention.
@nl
P2860
P921
P1433
P1476
How acceptable are antiretrovi ...... s and treatment as prevention.
@en
P2860
P2888
P304
P356
10.1007/S10461-013-0560-7
P577
2014-02-01T00:00:00Z